SALL4 expression is also detected in patient samples from blastic stage of chronic myeloid leukemia (CML), as contrast to the chronic phase, and CML patients who have achieved complete remission or those who have tyrosine kinase inhibitor resistance [59–61]. This evidence concerns the gene SALL4 and chronic myelogenous leukemia, BCR-ABL1 positive.